YES

NO

Hybrid Closed-Loop (HCL) Therapy for Women With Type 1 Diabetes Who Are Pregnant

Watch the recording now!

AIM:

The aim of this webinar is to outline the process and pathways for providing HCL therapy in pregnancy

FOCUS:

  • The NHS 5-year implementation strategy for HCL technologies
  • Maximising the benefits of HCL for women with Type 1 diabetes who are pregnant
  • Practical examples of how maternity services have put HCL onboarding protocols in place
  • Key considerations for ICS leads


SPEAKERS:

  • Eleanor M. Scott (Chair) - Professor of Medicine (Diabetes and Maternal Health), University of Leeds & Leeds Teaching Hospitals Trust
  • Partha Kar - Type 1 Diabetes & Technology Lead. Consultant Diabetes, Portsmouth Hospitals University NHS Trust
  • Helen R. Murphy - Professor of Medicine, University of East Anglia (UEA), Norwich UK, Honorary Consultant Physician, Norfolk & Norwich University NHS Hospital Trust, Chair National Pregnancy in Diabetes (NPID) audit
  • Nina Willer - Diabetes Specialist Midwife, Norfolk & Norwich University NHS Hospital Trust
  • Emma Wilmot – Associate Professor, University of Nottingham School of Medicine, Honorary Consultant Diabetologist,University Hospitals of Derby and Burton. Founder, Diabetes Technology Network UK
  • Karen Kennedy - Assistant Director, National Diabetes Programme, NHS England


WEBINAR RESOURCES:

Play video

Average Number Of Type 1 Diabetes Pregnancies And T1D Pregnant Pump Users 2022 2023 By ICB [20.30 KB]

Battelino Et Al Clinical Targets For Continuous Glucose Monitoring Data Interpretation [1.39 MB]

Benhalima Et Al Comparing Advanced HCL Therapy And Standard Insulin Therapy In Pregnant Women With Type 1 Diabetes CRISTAL [1.21 MB]

Feig Et Al CGM In Pregnant Women With T1D CONCEPTT [1.18 MB]

HCL Pregnancy Webinar Slide Deck Oct 2024 [4.90 MB]

Lawton Et Al Listening To Women Experiences Of Using Closed Loop In T1D Pregnancy [269.68 KB]

Lee At Al Automated Insulin Delivery In Women With Pregnancy Complicated With Type 1 Diabetes [570.06 KB]

Murphy Et Al Characteristics And Outcomes Of Pregnant Women With Type 1 And Type 2 Diabetes [1.71 MB]

Murphy Et Al Modelling Potential Cost Savings From Use Of Real Time CGM In T1D Pregnancy [242.09 KB]

Quiro S Et Al 2024 Real World Evidence Of Off Label Use Of Commercially Automated Insulin Delivery Systems Compared To [929.94 KB]

Scott Et Al CONCEPTT To Care The Science Of Implementation In Diabetes Care [125.43 KB]

Signing Up For FutureNHS [133.60 KB]

The Impact Of The Montgomery Ruling [130.28 KB]


loading